Cipla is engaged in the Business of Pharmaceuticals.
Financial Results:
Cipla Ltd reported Revenues for Q1FY24 of ₹6,329.00 Crores up from ₹5,375.00 Crore year on year, a rise of 17.75%.
Total Expenses for Q1FY24 of ₹5,090.00 Crores up from ₹4,504.00 Crores year on year, a rise of 13.01%.
Consolidated Net Profit of ₹998.00 Crores up 41.36% from ₹706.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹12.34, up 45.01% from ₹8.51 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.